Please provide your email address to receive an email when new articles are posted on . An oral, ultra-long-acting, extended-release risperidone capsule provided sustained therapeutic levels of ...

Risperidone is an antipsychotic drug that has been increasingly used for treatment and maintenance therapy in schizophrenia and related psychotic disorders. 1 Risperidone is metabolized to its active ...

January 5, 2012 — A new study shows that the antipsychotic drug risperidone is significantly superior to lithium and divalproex sodium for initial treatment of mania in children, and it is better ...

Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits. Teva Pharmaceuticals has announced positive ...

Skipping daily pills is a common problem in schizophrenia care. A new study in the US tested a once-weekly oral version of risperidone. The results show that the drug remained at therapeutic levels ...

The efficacy and safety of risperidone for the treatment of schizophrenia were established more than 15 years ago. [5,6] More recently, multinational placebo-controlled studies have shown paliperidone ...

A 30-year search for better antipsychotic drugs with fewer negative side effects may have taken another step forward thanks to researchers in Chapel Hill. Antipsychotic drugs are among the most widely ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of eight ...

A new review finds no evidence to support the use of risperidone to treat attention- deficit/hyperactivity disorder (ADHD) in people with intellectual disabilities, even though the review authors say ...